23andMe to buy online pharmacy Lemonaid for $400M October 22, 2021 Auto Bot 23andMe, direct-to-consumer, Health Services, Telehealth, Telemedicine 0 The company plans to pair its direct-to-consumer genetic testing with Lemonaid’s online coaching and prescription delivery. It plans to buy the company for $400 million in stock and cash.